Extreme hypertriglyceridemia in a patient with the onset of diabetes mellitus: clinical case
https://doi.org/10.51922/2616-633X.2026.10.1.2843
Abstract
The high prevalence of obesity and diabetes mellitus within the framework of metabolic syndrome opens up new challenges for us – increased triglycerides, elevated non-HDL cholesterol and Lp(a), this leading to an increase in atherosclerotic cardiovascular diseases. Extremely high hypertriglyceridemia is rarely detected, and it manifests in patients with diabetes mellitus in the form of complications such as acute pancreatitis. The article presents a clinical case of a 42-year-old woman with newly diagnosed type 2 diabetes associated with extreme hypertriglyceridemia, management and therapy having been discussed.
About the Authors
T. I. Makartsova
Grodno State Medical University
Belarus
Belarus
K. M. Surmach
Grodno State Medical University
Belarus
Belarus
V. S. Halyshka
Grodno State Medical University
Belarus
Belarus
V. A. Frolov
Grodno Clinical Hospital No. 3
Belarus
Belarus
I. A. Sinkevich
Grodno Clinical Hospital No. 3
Belarus
Belarus
P. V. Baluk
Grodno Clinical Hospital No. 3
Belarus
Belarus
A. V. Knysh
Grodno Clinical Hospital No. 3
Belarus
Belarus
References
1. Mach F., Baigent C., Catapano A.L. et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, vol. 41(1), pp. 111-188. doi: 10.1093/eurheartj/ehz455.
2. Gurevich V.S., Koziolova N.A., Ezhov M.V. et al. Unsolved problems of dyslipidemia and residual cardiovascular risk. Journal of atherosclerosis and dyslipidemias. 2022, vol. 1, no. 46, pp. 31-39. doi:10.34687/2219-8202.JAD.2022.01.0003. (in Russian).
3. Toth P.P. Triglycerides and atherosclerosis: bringing the association into sharper focus. J Am Coll Cardiol. 2021, vol. 77(24), pp. 3042-3045. doi: 10.1016/j.jacc.2021.04.058.
4. Singh A.K., Singh R. Triglyceride and cardiovascular risk: A critical appraisal. Indian J Endocrinol Metab. 2016, vol. 20(4), pp. 418-28. doi: 10.4103/2230-8210.183460.
5. Toth P.P., Shah P.K., Lepor N.E. Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review. Am J Prev Cardiol. 2020, vol. 3, pp. 100086. doi: 10.1016/j.ajpc.2020.100086.
6. Alexopoulos A.S., Qamar A., Hutchins K. et al. Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes. Curr Diab Rep. 2019, vol. 19(4), pp. 13. doi: 10.1007/s11892-019-1136-3.
7. Ridker P.M., Moorthy M.V., Cook N.R. et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-year cardiovascular outcomes in women. N Engl J Med. 2024, vol. 391(22), pp. 2087-2097. doi: 10.1056/NEJMoa2405182.
8. Russo G.T., Manicardi V., Rocca A. et al. Severe hypertriglyceridemia in patients with type 2 diabetes mellitus participating in the AMD Annals Initiative. Metab Syndr Relat Disord. 2024, vol. 22(9), pp. 661-668. doi: 10.1089/met.2024.0093.
9. Lee M.K., Han K., Kim B. et al. Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults. Diabetes Res Clin Pract. 2024, vol. 208, pp. 111109. doi: 10.1016/j.diabres.2024.111109.
10. Zhao X.C., Ju B., Wei N. et al. Severe hyperlipemia-induced pseudoerythrocytosis - Implication for misdiagnosis and blood transfusion: A case report and literature review. World J Clin Cases. 2020, vol. 8(19), pp. 4595-4602. doi: 10.12998/wjcc.v8.i19.4595.
11. Li J., Nie Z., Ge Z., et al. Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study. Lipids Health Dis. 2022, vol. 21(1), pp. 77. doi: 10.1186/s12944-022-01691-1.
12. Fishman M.L., McLaughlin M.A., Fuster V. Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence? Womens Health (Lond). 2009, vol. 5(6), pp. 617-23. doi: 10.2217/whe.09.59.
13. Marassi M., Fadini G.P. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023, vol. 22(1), pp. 195. doi: 10.1186/s12933-023-01937-x.
14. Ye X., Kong W., Zafar M.I., Chen L.L. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019, vol. 18(1), pp. 48. doi: 10.1186/s12933-019-0851-z.
15. Kristensen F.P.B., Christensen D.H., Mortensen M.B. et al. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study. Cardiovasc Diabetol, 2023, vol. 22(1), pp. 187. doi: 10.1186/s12933-023-01921-5.
16. Wang Y., Fang Y., Magliano D.J. et al. Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes. Cardiovasc Res, 2023, vol. 119(3), pp. 826-834. doi: 10.1093/cvr/cvac124.
17. American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care, 2024, vol. 47(Suppl 1), pp. S179-S218. doi: 10.2337/dc24-S010.
Review
For citations:
Makartsova T.I., Surmach K.M., Halyshka V.S., Frolov V.A., Sinkevich I.A., Baluk P.V., Knysh A.V. Extreme hypertriglyceridemia in a patient with the onset of diabetes mellitus: clinical case. Emergency Cardiology and Cardiovascular Risks journal. 2026;10(1):2843-2848. (In Russ.) https://doi.org/10.51922/2616-633X.2026.10.1.2843
Views:
39
JATS XML
Email this article 